You are here: Home
Categories

Phosphodiesterase (PDE):

1. Beyond the Abstract - Are phosphodiesterase type 5 Inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature, by Faris Azzouni and Khawla Abu Samra
BERKELEY, CA (UroToday.com) - Phosphodiesterase (PDE) is the enzyme responsible for the degradation of cyclic guanosine monophosphate (cGMP) and cyclic adenine monophosphate (cAMP) to GMP and AMP, respectively. ...
2. Beyond the Abstract - The future is today: Emerging drugs for the treatment of erectile dysfunction, by Maarten Albersen, MD
BERKELEY, CA (UroToday.com) - Erectile Dysfunction (ED) is the most common male sexual dysfunction presented for treatment, and the most thoroughly studied sexual dysfunction in men.
3. PDEI-5 for erectile dysfunction: A potential role in seizure susceptibility, "Beyond the Abstract," by Gabriela Matos, PhD, Sergio Tufik, MD, PhD, and Monica L. Andersen, PhD
BERKELEY, CA (UroToday.com) - Epilepsy is one of the most common chronic neurological diseases, affecting people of all ages and genders around the world.